ELAB - Elevai Corp Total Debt to Capital

Elevai Labs Inc. (ELAB) maintains a stable liquidity level, with revenue from premium cosmetics fully offsetting current expenses. This daily price chart for the total debt-to-equity metric stands at 0.83, complementing management's strategy to implement regenerative technologies into aesthetic medicine. The production of innovative products is based in a California complex, where international quality standards are strictly observed.

ELAB: Elevai Labs Total Debt to Capital 02/21/2024 - 10/30/2026

Analytical breakdowns for Elevai Labs Inc.

- price and consensus price forecast:

Price Chart Elevai Labs|ELAB - Forecast Levels Chart

- market capitalization statistics:

Market Capitalization Elevai Labs|ELAB - Value Adjusted for Debt and Cash

- book capitalization indicators:

Book Value per Share Elevai Labs|ELAB - Book Capitalization|Market Value to Book Value Ratio elevaiskincare.com|ELAB - Aggregate Asset Value

- company total debt and liquidity indicators:

- earnings and valuation multiples information:

ELAB - Net Profit

Basic company analysis:Elevai Labs

The total debt-to-equity ratio measures the proportion of borrowed funds relative to equity, determining the extent to which the financing structure depends on creditors. By analyzing the company's financial leverage dynamics, an investor assesses the default resilience of Elevai Labs Inc. (ELAB), taking into account the high capital expenditures required to maintain a specialized cold chain for the delivery of exosome serums.

Competitor analysis for Elevai Labs Inc.